Fed. Circ. Won't Review Nix Of Merck's $2.5B IP Win

The Federal Circuit on Friday denied a Merck & Co. subsidiary's bid for the full court to review a panel decision that wiped out a $2.5 billion verdict in a patent...

Already a subscriber? Click here to view full article